-
NEJM: Interleukin 17A/17F dual inhibitor Bimekizumab in the treatment of moderate to severe plaque psoriasis
Time of Update: 2021-05-08
The study found that for patients with moderate to severe plaque psoriasis, the clinical effect of bimekizumab, a dual interleukin 17A/17F inhibitor, is better than the choice of interleukin 17A inhibitor Secukinumab, but the risk of oral Candida infection is higher .
-
Skin with erythema, papules, wind masses, and burning, itching, beware of "photosensitivity"!
Time of Update: 2021-05-08
Sometimes, photosensitivity is not directly caused by sun exposure to the skin, and requires the participation of some photosensitive substances, such as photosensitive foods, certain chemicals and drugs.
-
Flt3 inhibitor AML produces CR: talk about off-target...
Time of Update: 2021-05-03
Luxe was originally developed as a reversible BTK inhibitor and its main use is chronic leukemia, but so far it is still a substitute goalkeeper in this arena.
-
Father retires and mother resigns to guard children with rare diseases 24 hours a day to create miracles of life
Time of Update: 2021-05-03
5em; width: 2em; height: 2em; border-radius: 1em; margin-top: -1em; margin-left: -1.
5em; width: 2em; height: 2em; border-radius: 1em; margin-top: -1em; margin-left: -1.
More than three years ago, 5-month-old Mu Mu (pseudonym) was unfortunately diagnosed with spinal muscular atrophy at Hunan Provincial People's Hospital.
-
AstraZeneca acquires well-known pharmaceutical company
Time of Update: 2021-05-02
In the 10 years from 2001 to 2010, the growth rate of the global rare disease drug market was 25.
8%, which was higher than the growth rate of the non-rare disease drug market (20.
-
Amgen's bispecific antibody AMG 570 is approved in China...
Time of Update: 2021-05-02
AMG 570 is a bispecific antibody developed by Amgen that can simultaneously target BAFF and ICOSL and is intended to be used to treat diseases such as systemic lupus erythematosus.
-
Diabetes drug market: Eli Lilly and Novo Nordisk compete fiercely, Sanofi exits
Time of Update: 2021-05-02
At that time, the FDA approved Ozempic (semaglutide subcutaneous injection) as a new indication for reducing adult type 2 The risk of cardiovascular events (MACE) in patients with diabetes and other cardiovascular diseases (CVD), including cardiovascular infarctions, non-fatal heart attacks, or non-fatal strokes.
-
"Pharmaceutical Speed Reading Society"'s first domestically produced mRNA COVID-19 vaccine approaches phase III clinical trials
Time of Update: 2021-05-02
[April 13th, 2021 / Medical Information List] The first domestically produced mRNA COVID-19 vaccine is close to phase III clinical trials; Henlius's new indication for adalimumab has been approved; Guizhou Moutai 1.
-
Positive progress in tumor electric field therapy for lung cancer Zai Lab owns rights in Greater China
Time of Update: 2021-05-02
Today, Novocure announced that its Tumor Treating Fields (TTF) has made positive progress in a pivotal Phase 3 clinical trial for the treatment of patients with non-small cell lung cancer.
-
The State Food and Drug Administration revised the drug inserts for tramadol suppositories and compound preparations
Time of Update: 2021-05-02
The use of this product during lactation may lead to the risk of serious adverse reactions in breastfed infants, including excessive sleepiness, difficulty in breastfeeding, or may cause severe breathing problems or even death.
-
PI3K dual inhibitor!
Time of Update: 2021-05-02
's Duensibu Capsules (trade name: Kebituo) has been approved by the China National Medical Products Administration ( NMPA) accepted and received conditional approval for listing and priority review qualifications.
[1]Voluntary Announcement-The National Medical Products Administration accepts the listing application of "Duensibu Capsules".
-
Latest research | Aging causes muscle loss!
Time of Update: 2021-05-02
A recent study published in "Stem Cell Research & Therapy" found that using a small artificial molecule called givinostat to induce stem cells to differentiate into muscle progenitor cells or muscle cells can promote muscle repair and regeneration.
-
Cansino: 13-valent pneumococcal polysaccharide conjugate vaccine enters phase III clinical trial
Time of Update: 2021-05-02
Streptococcus pneumoniae is the cause of children lung inflammation, meningitis, bacteremia and other major pathogens serious diseases, but also cause acute otitis media and sinusitis and other common causes.
-
How do scientists predict the risk of humans suffering from multiple diseases?
Time of Update: 2021-04-29
1038/s41551-020-00626-4Recently, in a research report published in the international journal Nature Biomedical Engineering, scientists from Singapore’s National Eye Center and other institutions have developed a new method using artificial intelligence technology to predict the risk of individuals suffering from cardiovascular disease.
-
The genes inherent in the body may affect the response to cancer immunotherapy!
Time of Update: 2021-04-29
February 27, 2021 // - Recently, in a research report entitled "Germline genetic contribution to the immune landscape of cancer" published in the international journal Immunity , scientists from the University of California and other institutions said through research , The body’s response to cancer immunotherapy may be affected by the genes carried by our body at birth.
-
Science Sub-Journal: Revealing that radiotherapy and immunotherapy restrict tumor progression by removing extramedullary red blood cell precursor cells
Time of Update: 2021-04-29
The relevant research results were published in the journal Science Translational Medicine on February 24, 2021, with the title of the paper "Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity".
-
Scientists are expected to develop a bacterial therapy to treat human eczema!
Time of Update: 2021-04-29
February 27, 2021 // - Recently, a research report entitled "Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial" was published in the international journal Nature Medicine In, scientists from the University of California and other institutions through research are expected to use bacteria to successfully resist bacteria that accelerate the occurrence of eczema.
-
Does the benefit of drinking green tea outweigh the disadvantages or the disadvantages outweigh the advantages?
Time of Update: 2021-04-29
032273Recently, in a research report published in the international journal Stroke, scientists from Osaka University and other institutions found through research that stroke and heart attack survivors may be able to drink green tea to reduce the risk of death from multiple causes, and it is expected to be later Prevent the occurrence of cardiovascular disease events.
-
Many articles focus on the mysterious connection between microRNA and cancer!
Time of Update: 2021-04-29
html">Oncotarget: A new type of microRNA may target the production of prostaglandin E2 in lung cancer cells, which is expected to help treat lung cancer!bioon.
html">Oncotarget: The new microRNA may target the production of prostaglandin E2 in lung cancer cells, which is expected to help treat lung cancer!doi: 10.
-
Front Immunol: Innate immune system will aggravate COVID19 symptoms
Time of Update: 2021-04-29
627579Information source: com/news/2021-02-innate-immune-worsens-situation-severe.
627579Information source: com/news/2021-02-innate-immune-worsens-situation-severe.
html">Innate immune system worsens the situation in severe COVID-19Original source: Miklós Lipcsey et al.
html">Innate immune system worsens the situation in severe COVID-19Original source: Miklós Lipcsey et al.
627579Original Source: com/news/2021-02-innate-immune-worsens-situation-severe.
